Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Genfit S.A. ADR (NQ: GNFT ) 4.220 -0.130 (-2.99%) Streaming Delayed Price Updated: 3:59 PM EDT, Jul 9, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 3,103 Open 4.350 Bid (Size) 4.220 (5) Ask (Size) 4.340 (3) Prev. Close 4.350 Today's Range 4.220 - 4.350 52wk Range 2.893 - 6.050 Shares Outstanding 38,888,379 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News FDA Fast-Tracks Ipsen And Genfit's New Liver Disease Treatment, Iqirvo June 11, 2024 The U.S. FDA has granted accelerated approval for Iqirvo, a novel drug from Ipsen SA and Genfit SA, designed for treating primary biliary cholangitis (PBC). This approval, based on the drug's ability... Via Benzinga Exposures Product Safety Why SentinelOne Shares Are Trading Lower By 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session May 31, 2024 Via Benzinga Performance YTD +4.71% +4.71% 1 Month -23.76% -23.76% 3 Month +21.97% +21.97% 6 Month +11.35% +11.35% 1 Year +5.50% +5.50% More News Read More 12 Health Care Stocks Moving In Friday's Pre-Market Session May 31, 2024 Via Benzinga Analyst Expectations for Genfit's Future July 03, 2023 Via Benzinga Genfit To Buy This Swiss Firm Expanding Its Portfolio in Liver Diseases September 19, 2022 Via Benzinga Why Zscaler Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket May 31, 2024 Via Benzinga Earnings Scheduled For April 4, 2024 April 04, 2024 Via Benzinga Why CymaBay Morphed From Dollar Stock To Biotech Rocket December 28, 2023 Via Investor's Business Daily 12 Health Care Stocks Moving In Tuesday's Pre-Market Session November 14, 2023 Via Benzinga Why CymaBay, With 172% Growth This Year, Just Surged For A Second Day Running September 08, 2023 Via Investor's Business Daily Intercept Pharma Gets Double Upgrade: Analyst Says OCA Combo Therapy Can Extend PBC Business July 13, 2023 Via Benzinga Genfit's Miss Is CymaBay Therapeutics' Gain: Analyst Says Rival Data Leaves Room for Seladelpar To Emerge As Best-In-Class June 30, 2023 Via Benzinga Ipsen, Genfit's Elafibranor Shows Promise In Primary Biliary Cholangitis Patients June 30, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session June 30, 2023 Via Benzinga Why Renalytix Are Trading Higher By Over 48%; Here Are 20 Stocks Moving Premarket June 30, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday June 30, 2023 Via InvestorPlace Former Wall Street Darling Intercept Restructures After FDA Rejects Its Liver Drug June 23, 2023 Via Investor's Business Daily 12 Health Care Stocks Moving In Thursday's Pre-Market Session June 22, 2023 Via Benzinga What Now After FDA AdComm Rebuke for Intercept Pharmaceutical? Analyst Says Approval Of Intercept's 'OCA In NASH May Never Occur May 22, 2023 Via Benzinga Earnings Scheduled For April 13, 2023 April 13, 2023 Via Benzinga The 7 Best Biotech Stocks to Buy for February 2023 February 07, 2023 Via InvestorPlace 12 Health Care Stocks Moving In Monday's Pre-Market Session October 10, 2022 Via Benzinga Earnings Scheduled For September 28, 2022 September 28, 2022 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session September 22, 2022 Via Benzinga US Stock Futures Rise After Recording Worst Sell-Off Since June 2020; PPI Data In Focus September 14, 2022 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
